BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to ...
One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and therapeutics, ...
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia ...
Treatment with personalised neoantigen DNA vaccines is feasible, says a clinical-trial-based study published in Genome ...
INOVIO (NASDAQ: INO) has released its financial results for the third quarter of 2024, alongside updates on significant ...
Graham first established The Graham Fulford Charitable Trust in 2004, with the primary aim to provide Prostate Specific ...
Medical professionals have long known that the earlier a disease is detected, the higher the chance for a better patient outcome.
Vulnerable patients like Fred can be unnecessarily prescribed antibiotics while they wait for pathology test results to ...